Evaluating a Decision Aid for Deep Brain Stimulation in Parkinson’s Disease: Results of a Pre–Post Pilot Study
Objective: To evaluate the impact of a deep brain stimulation (DBS) decision aid for DBS for patients with Parkinson’s disease (PD). Background: The decision to…The Relationship Between Substantia Nigra Hyperchogenicity and Clinical Features and Disease Progression in Parkinson’s Disease Patients
Objective: To investigate the relationship between substantia nigra hyperechogenicity (SN+) and clinical features and disease progression in patients with Parkinson's disease (PD) under transcranial sonography…Mild Motor Impairments in Rapid Eye Movement Behavior Disorder: Tremor and Bradykinesia
Objective: We investigated patients with RBD to identify mild motor impairments through the objective quantification of sensitive motor control assays. Background: It is established that…Characterising immune changes in the nose in Parkinson’s disease
Objective: To characterise the profile of innate immune cells in the nasal cavity in people with Parkinson’s disease (PD) versus controls. Background: Neuroinflammation provides novel…Feasibility and Preliminary Outcomes of an Online Fatigue Self Management Programme for People With Parkinsons Disease
Objective: To assess the feasibility, acceptability, and preliminary outcomes of an online fatigue self management programme for people with Parkinsons disease. Background: Fatigue is a…A Novel Clinical Protocol for Monitoring Therapeutic Outcomes in Camptocormia in Parkinson´s Disease
Objective: To present a case study using a novel protocol evaluating postural, pain, and respiratory outcome in PD-related camptocormia before and after treatment. Background: Camptocormia…Association of Sarcopenia with Fear of Falling and Falls in patients with Parkinson’s disease
Objective: This study aimed to determine whether Sarcopenia is related to the risk of falls and to the Fear of Falling (FOF) in patients with…Two Voices, One Disease: Patient and Care Partner Decision Dynamics on Advanced Therapies for Parkinson’s Disease
Objective: To characterize decision dynamics between patients with Parkinson’s disease (PwP) and their care partners (CP) on initiation of advanced therapies. Background: Factors guiding decisions…Exploring the Causal Role of Mitochondria-related Genes in Parkinson’s Disease through Multi-Omics Mendelian Randomization
Objective: To investigate the causal roles of mitochondria-related gene expression in the pathogenesis of Parkinson's Disease (PD). Background: Mitochondria-related gene expression has been implicated in…Electronic Health Record Integration Improves Markerless 3D Gait-Based Prediction of Parkinson’s Disease Motor Symptom Severity
Objective: To evaluate if integrating electronic health record (EHR) data with markerless 3D gait kinematics improves prediction of Parkinson's disease (PD) motor symptom severity. Background:…
- « Previous Page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- …
- 553
- Next Page »
